Target intelligence / Profile preview

General cellular and tissue microenvironment

Molecular classification
Other
01

Overview

The general cellular and tissue microenvironment is a complex, multi-component system consisting of the extracellular matrix (ECM), interstitial fluid, signaling molecules such as cytokines and growth factors, and various non-parenchymal cells like fibroblasts, immune cells, and endothelial cells (Frantz et al., 2010, Journal of Cell Science). It serves as a critical regulator of cellular behavior, providing both structural support and biochemical cues that influence cell survival, proliferation, and differentiation (NCI Dictionary). In pathological states, particularly cancer, the tumor microenvironment (TME) is often characterized by hypoxia, acidity, and an immunosuppressive landscape that promotes disease progression and therapeutic resistance (Binnewies et al., 2018, Nature Medicine). Therapeutic interventions targeting this environment do not focus on a single receptor but rather aim to reprogram the niche, such as by inhibiting angiogenesis with VEGF blockers or degrading the ECM to improve drug delivery (Anderson & Simon, 2020, Nature Reviews Cancer). Consequently, while it is a major focus of drug development, it represents a physiological context or a collection of targets rather than a discrete molecular target entity.

Other names
Tumor microenvironmentTMEExtracellular matrixCellular nicheStromaTissue landscape
02

Mechanism of action

Modulation of the extracellular matrix, inhibition of angiogenesis, alteration of immune cell infiltration, and normalization of physiological conditions such as hypoxia and acidity (Anderson & Simon, 2020, Nature Reviews Cancer).

03

Biological functions

Structural supportSignal transductionImmune regulationMetabolic regulationCell-cell communicationNutrient and waste transport
04

Disease associations

CancerInflammationFibrosisCardiovascular diseaseWound healingMetabolic disorders
05

Safety considerations

Systemic toxicityImpaired wound healingAutoimmune-related adverse events (irAEs)Disruption of normal tissue homeostasisOff-target effects on healthy tissue architecture
06

Interacting drugs

Bevacizumab

5 more in the full profile.

07

Biomarkers

Hypoxia-inducible factor 1-alpha (HIF-1α)Vascular endothelial growth factor (VEGF)Tumor-infiltrating lymphocytes (TILs)Matrix metalloproteinases (MMPs)Lactate levelsPD-L1 expression

Beyond the preview

Go deeper on General cellular and tissue microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular and tissue microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call